Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tumor-propagating side population cells are a dynamic subpopulation in undifferentiated pleomorphic sarcoma
Yuning Jackie Tang, Vijitha Puviindran, Yu Xiang, Yasuhito Yahara, Hongyuan Zhang, Puviindran Nadesan, Yarui Diao, David G. Kirsch, Benjamin A. Alman
Yuning Jackie Tang, Vijitha Puviindran, Yu Xiang, Yasuhito Yahara, Hongyuan Zhang, Puviindran Nadesan, Yarui Diao, David G. Kirsch, Benjamin A. Alman
View: Text | PDF
Research Article Oncology

Tumor-propagating side population cells are a dynamic subpopulation in undifferentiated pleomorphic sarcoma

  • Text
  • PDF
Abstract

Sarcomas contain a subpopulation of tumor-propagating cells (TPCs) with enhanced tumor-initiating and self-renewal properties. However, it is unclear whether the TPC phenotype in sarcomas is stable or a dynamic cell state that can derive from non-TPCs. In this study, we utilized a mouse model of undifferentiated pleomorphic sarcoma (UPS) to trace the lineage relationship between sarcoma side population (SP) cells that are enriched for TPCs and non-SP cells. By cotransplanting SP and non-SP cells expressing different endogenous fluorescent reporters, we show that non-SP cells can give rise to SP cells with enhanced tumor-propagating potential in vivo. Lineage trajectory analysis using single-cell RNA sequencing from SP and non-SP cells supports the notion that non-SP cells can assume the SP cell phenotype de novo. To test the effect of eradicating SP cells on tumor growth and self-renewal, we generated mouse sarcomas in which the diphtheria toxin receptor is expressed in the SP cells and their progeny. Ablation of the SP population using diphtheria toxin did not impede tumor growth or self-renewal. Altogether, we show that the sarcoma SP represent a dynamic cell state and targeting TPCs alone is insufficient to eliminate tumor progression.

Authors

Yuning Jackie Tang, Vijitha Puviindran, Yu Xiang, Yasuhito Yahara, Hongyuan Zhang, Puviindran Nadesan, Yarui Diao, David G. Kirsch, Benjamin A. Alman

×

Figure 1

Side population cells in KPCC tumors enrich for TPCs.

Options: View larger image (or click on image) Download as PowerPoint
Side population cells in KPCC tumors enrich for TPCs.
(A) Representative...
(A) Representative FACS gating schematic for side population (SP) and non-SP cells in KPCC tumors (n > 3). (B) Average percentage of CD45– SP cells in KPCC tumors (n = 3). Error bars represent mean ± SEM. (C) SP and non-SP cells in KPCC tumors express different florescent reporters (n = 3). (D) Extreme limiting dilution analysis (ELDA) shows that SP cells are significantly enriched for tumor-propagating potential compared with non-SP cells in nude mice (χ2 = 87.7, df = 1, P = 7.74 × 10–21). The dotted line indicates the 95% confidence interval. (E) ELDA shows that SP cells are significantly enriched for tumor-propagating potential compared with non-SP cells in NSG mice (χ2 = 30.4, df = 1, P = 3.45 × 10–8). The dotted line indicates the 95% confidence interval.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts